KCT0009000尚未招募Unknown
Efficacy and Safety of 1L Polyethylene Glycol plus Low-dose Ascorbic Acid Compared to D-Sorbitol and Picosulfate plus Ascorbic Acid: Multi-center, randomized, single-blind prospective study
Chung-Ang Univerisity Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •The following are the inclusion criteria for patients eligible to participate in the study:
- •Adult men and women aged 19 years and above.
- •Patients scheduled to undergo colonoscopy for screening or diagnostic purposes at the Gastroenterology outpatient departments of Chung-Ang University Hospital and Chung-Ang University Gwangmyeong Hospital from the start of the study.
- •Patients who have provided informed consent to participate in the study.
排除标准
- •The following are the criteria for excluding patients from participating in the study:
- •1. Patients with functional or anatomical gastrointestinal obstructions (such as gastric paresis, pyloric stenosis, functional bowel obstructions, toxic megacolon, etc.), active gastrointestinal bleeding, or intestinal perforation.
- •2. Patients with dehydration, severe vomiting, or severe diarrhea.
- •3. Patients with a history of or current inflammatory bowel disease (Crohn's disease or ulcerative colitis) or those strongly suspected of having such conditions.
- •4. Patients with confirmed gastric ulcers.
- •5. Patients with a known history of intestinal adhesions that require surgery, or those in an acute abdominal condition requiring surgical intervention.
- •6. Patients with a history of previous gastrointestinal resection surgery (excluding appendectomy).
- •7. Patients with a history of glucose-6-phosphate dehydrogenase deficiency.
- •8. Patients with significant cardiovascular diseases (New York Heart Association classification III and IV), respiratory diseases, kidney disease (creatinine clearance <30mL/min), liver disease, or a combination of these conditions.
- •9. Patients with dementia, cognitive impairment, or altered consciousness.
- •10. Patients with a history of cardiac arrest.
- •11. Patients with known hypersensitivity or allergic reactions to the medications used.
- •12. Pregnant and lactating women.
- •13. Patients who do not provide informed consent for the study.
- •14. Other patients deemed unsuitable for the study by the principal investigator or study personnel.
研究者
相似试验
尚未招募
4 期
Can polyethylene glycol solution be used as an alternative to lactulose in patients of hepatic encephalopathy ?CTRI/2024/02/062513I
进行中（未招募）
1 期
Randomized controlled study to assess the efficacy of a very low-volume Polyethylene Glycole (PEG 1L) bowel preparation vs. low-volume (2L) and high-volume (4L) PEG-based preparations, among patients who undergo bowel purge for colonoscopy during in hospital stay.Adult in hospital patients who undergo colonoscopy for any medical diseaseMedDRA version: 21.0Level: PTClassification code 10010007Term: ColonoscopySystem Organ Class: 10022891 - InvestigationsEUCTR2019-002799-15-ITALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA800
招募中
3 期
Comparison of the effect of Polyethylene Glycol (Single dose vs divided dose) in Treatment of Functional Constipation in ChildreConstipation.K59.0ConstipationIRCT20090908002434N9Shiraz University of Medical Sciences80
已完成
3 期
Comparison of the effect of polyethylene glycol syrup and lactulose syrup in children aged 1 to 15 years with chronic functional constipatiochronic functional constipation.K59.0ConstipationIRCT20171015036783N2Shahid Beheshti University of Medical Sciences100
尚未招募
不适用
POLYETHYLENEGLYCOL, ELECTROLYTES AND PROBIOTICS IN CONSTIPATION IN CHILDRECTRI/2022/06/043454SHIVAKUMAR NALUBOLA